je.st
news
StemCells, Inc. Acquires Seminal Neural Stem Cell Patent Portfolio
2013-10-30 05:24:33| drugdiscoveryonline News Articles
StemCells, Inc. (Nasdaq:STEM) today announced the acquisition of a portfolio of issued US and Canadian patents to which it had previously held an exclusive worldwide license
Tags: cell
portfolio
stem
patent
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|